Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer's Disease.

Journal of Alzheimer's disease : JAD - 1 Jan 2020

Faura Júlia, Bustamante Alejandro, Penalba Anna, Giralt Dolors, Simats Alba, Martínez-Sáez Elena, Alcolea Daniel, Fortea Juan, Lleó Alberto, Teunissen Charlotte E, van der Flier Wiesje M, Ibañez Laura, Harari Oscar, Cruchaga Carlos, Hernández-Guillamón Mar, Delgado Pilar, Montaner Joan

Abstract excerpt

CCL23 is a chemokine implicated in inflammation and host defense responses. It has been recently associated with acquired brain damage and stroke outcomes. In this study, we reported the role of CCL23 in Alzheimer's disease (AD). We evaluated the levels of CCL23 in 659 individuals: cognitively normal, mild cognitive impaired (MCI), and AD patients. Two cross-sectional (study 1, n = 53; study 2, n = 200) and two...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein E4
Share to Chemokines, CC

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognitive Dysfunction

Share to Early Diagnosis

Share to Kaplan-Meier Estimate

Share to Longitudinal Studies

Share to Mental Status and Dementia Tests

Share to Predictive Value of Tests

Source

Open in PubMed Open full text

Identifiers

PMID: 31958084
DOI: 10.3233/JAD-190753
PMCID: PMC8010612

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer's Disease.PMID 31958084Read ↗

Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer's Disease and Mild Cognitive Impairment: A Two-year Follow-up Study.Semantic proximity Read ↗

The CCL2 rs4586 SNP Is Associated with Slower Amyloid-β Deposition and Faster Tau Accumulation of Alzheimer's Disease.Semantic proximity Read ↗

Convergent transcriptomic and genomic evidence supporting a dysregulation of CXCL16 and CCL5 in Alzheimer’s diseaseSemantic proximity Read ↗

MicroRNA deregulation and chemotaxis and phagocytosis impairment in Alzheimer's diseaseSemantic proximity Read ↗

Association of the CX3CR1-V249I Variant with Neurofibrillary Pathology Progression in Late-Onset Alzheimer's Disease.Semantic proximity Read ↗

Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice.Semantic proximity Read ↗

Blood levels of MCP-1 modulate the genetic risks of Alzheimer's disease mediated by HLA-DRB1 and APOE for Alzheimer's disease.Semantic proximity Read ↗

MCP‐1 and eotaxin‐1 selectively and negatively associate with memory in MCI and Alzheimer's disease dementia phenotypesSemantic proximity Read ↗

A focus on CXCR4 in Alzheimer's diseaseSemantic proximity Read ↗

Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment.Semantic proximity Read ↗

Functional significance of NLRP3 polymorphisms in mild cognitive impairment.Semantic proximity Read ↗

Double negative (IgG+IgD-CD27-) B cells are increased in a cohort of moderate-severe Alzheimer's disease patients and show a pro-inflammatory trafficking receptor phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.